Nucleoside analogues
US5580571A · kind A · utility
34Cited by
10References
23Claims
0Family size
Inventor
Key dates
| Filing date | May 12, 1993 |
| Grant date | Dec 3, 1996 |
| Priority date | — |
| Expiry date | May 12, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions for topical use in herpes virus infections comprising anti-herpes nucleoside analogue phosphate esters, such as acyclovir monophosphate and acyclovir diphosphate, which show increased activity against native strains of herpes virus as well as against resistant strains, particularly thymidine kinase negative strains of virus. Also disclosed are methods for using the topical compositions in treatment of herpes disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.